Overview

Cardinal Health 414, LLC is a subsidiary of Cardinal Health, Inc., a global healthcare services and products company. The company focuses on providing pharmaceutical and medical products and services to various healthcare providers, enhancing healthcare efficiency and outcomes.

Therapeutic areas

Pharmaceutical DistributionMedical Products

API / Drug Master Files

Cardinal Health 414, LLC holds 3 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • ACTINIUM (225AC) NITRATE SOLUTIONActive2024-12-19
  • GALLIUM GA-68 CHLORIDE SOLUTIONActive2024-04-18
  • TETRAKIS (2-METHOXYISOBUTYLISONITRILE) COPPER (I) TETRAFLUOROBORATE DRUG SUBSTANCEActive2006-12-22
  • SODIUM ACETATE C-11 INJECTIONInactive2011-01-19
  • FLUOROMISONIDAZOLE F18 INJECTION([18F]FMISO)Inactive2009-06-16
  • 3-DEOXY-3-[18F]FLUOROTHYMIDINE ([18F]FLT)Inactive2009-04-03
  • SODIUM FLUORIDE F18 INJECTIONInactive2008-08-29
  • FLUOROMISONIDAZOLE F 18 INJECTIONInactive2008-06-12

FDA compliance signals

50 FDA enforcement records linked to this company.

  • 4832026-03-18

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832026-02-06

    Written QA procedures established, followed

  • 4832026-02-06

    Non-Conforming Product Investigation Incomplete

  • 4832026-02-06

    Complaint record contents

  • 4832026-02-06

    Correction of problems

  • 4832025-09-12

    Cleaning / Sanitizing / Maintenance

  • 4832025-09-12

    In-process samples representative, identified properly

  • 4832025-09-12

    Investigations of discrepancies, failures

  • 4832025-08-28

    Specifications and processes

  • 4832025-07-31

    Documentation of Non-Conforming Product Investigation

  • 4832025-07-31

    Correction of problems

  • 4832025-07-31

    Lack of disinfection, equipment/supplies from lower to higher quality air

  • 4832025-07-31

    Written QA procedures established, followed

  • 4832025-07-31

    Personnel, blocked or disrupted first air

  • 4832025-07-01

    Lab written procedures

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.